FDA approves 'Jascayd for progressive pulmonary fibrosis: What it means for patients

Exciting news for those affected by progressive pulmonary fibrosis (PPF): The US FDA has granted approval for Jascayd (nerandomilast). This groundbreaking medication goes beyond merely alleviating symptoms, presenting a scientifically validated way to decelerate lung damage.

source https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/fda-approves-jascayd-for-progressive-pulmonary-fibrosis-what-it-means-for-patients/articleshow/126125581.cms